NL-OMON28302已完成不适用
Renal hemodynamic effects of aliskiren (rasilez) in comparison to ramipril (tritrace) in patients with overweight/obesity and hypertension.
niversity Medical Center Groningen (UMCG)0 个研究点目标入组 16 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 16
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Male caucasian patients;
- •2. Age >18 and <70 years;
排除标准
- •1. Inability to meet inclusion criteria;
- •2. Previously treated (within 3 months prior to start of study) with aliskiren or ramipril;
研究者
相似试验
已完成
3 期
Renal hemodynamic effects of aliskiren (rasilez) in comparison to ramipril (tritrace) in patients with overweight/obesity and hypertensiosystemische en glomerulaire hypertensieelevated blood pressure in the kidneyglomerular hypertensionNL-OMON34045niversitair Medisch Centrum Groningen16
进行中（未招募）
不适用
Renal Hemodynamic Effects of ALiskiren (rasilez) in comparison to ramipril (Tritrace) in patients with overweigHt/obeSiTy and UntreateD hYpertension: The renal HEALTH-STUDY - The renal HEALTH-STUDYEUCTR2010-021987-13-NLniversity Medical Center Groningen16
Unknown
4 期
A Prospective Study of the Kidney Protective Effect of Aliskiren in Hypertensive Patients With IgA NephropathyGlomerulonephritis, IGAHypertensionNCT01184599Kagawa University30
进行中（未招募）
不适用
Effects of rosiglitazone on renal hemodynamics and proteinuria of type 2 diabetic patients with renal insufficiency due to overt diabetic nephropathytype 2 diabetic patients with proteinuria and chronic renal failure due to overt diabetic nephropathyEUCTR2005-002407-17-DETechnical University Dresden38
终止
4 期
Effect of the Direct Renin Inhibitor Aliskiren on Endothelial Function and Arterial Stiffness in Diabetic SubjectsPre-hypertensionHypertensionDiabetesNCT01349114University of Alabama at Birmingham21